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Sphaeranthus indicus Linn. commonly known as 
Gorakh Mundi is an annual spreading herb which 
grow  up  approximately  16-30cm  height, the plant is 
Address for correspondence: 
 
Dr. Seema Pradeep 
Professor & Head, Department Of  Dravyaguna, Sri Sri College Of 
Ayurvedic Science and Research, Bangalore, Karnataka, INDIA. 
E-mail: drvikramayur@gmail.com 
 
Submission Date: 27/08/2019 Accepted Date: 10/10/2019 
Access this article online 




distributed throughout the plains and wet lands of 
India. Traditionally it is used for the treatment of 




The plant is known to possess varied medicinal 
properties and is reportedly used in classical 
Ayurvedic preparations for treating many disorder. 
This study was aimed over view on traditional use of 
the drug Gorakh Mundi, its phytochemical, 
pharmacological investigation and experimental 




Nephrotoxcity is one of the most common kidney 
problem and occurs, when body is exposed to a drug 
or toxins. A number of therapeutic agents can 
adversely affect the kidney resulting in acute renal 
A B S T R A C T  
Background: Sphaeranthus indicus Linn. (Mundi) is a medicinal plant widely used in Indian traditional 
and folk systems of medicine for treating various ailments. In the Indian system of medicine, the plant 
as a whole plant or its different anatomical parts viz., leaf, stem, bark, root, flower and seed are 
widely used for curing many diseases. The plant is bitter, stomachic, restorative, alterative, pectoral, 
demulcent and externally soothing. Aim: The present study was undertaken to scientifically evaluate 
the nephroprotective activity of the aqueous extract & ethanolic extract of Mundi, Sphaeranthus 
indicus Linn. Methedology: Experimental grouping, Group-1 served as health control; received 
purified water (5ml/kg, p.o.). Group -2 served as Nephrotoxic control; This group of animals received 
daily i.p. injection of gentamicin (80mg/kg body weight) for eight days. Group 3,4,5,6 animals of this 
group received 80 mg/kg of gentamicin i.p. nearly for eight days in addition to this they also received 
aqueous extract low dose (200mg), aqueous extract high dose (400mg), ethanolic extract low dose 
(200mg) and ethanolic extract high dose (400mg) respectively which was started three days prior to 
the gentamicin injection and continued with 8 days gentamicin treatment. Histopathological studies on 
isolated kidney revealed that the aqueous extract & ethanolic extract of Sphaeranthus indicus Linn, 
reversed the kidney damage and also restored normal kidney architecture. Statically Values are 
expressed in mean ± S.E.M. (n=6), ** = p<0.01 and *** = p<0.001. Conclusion: The aqueous 
extract & ethanolic extract of Sphaeranthus indicus Linn. showed statistically significant 
nephroprotective activity. The plant extract proved to have nephroprotective potentials may because 
of its known flavonoids, saponins, tannins, and phenolic compounds.  
Key words: Nephroprotective activity, Sphaeranthus indicus Linn., Mundi, Gorakh Mundi, Gentamicin. 
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failure, chronic interstitial nephritis and nephritic 
syndrome, because there is an increasing number of 
potent therapeutic drugs like amino glycoside, 
antibiotics, NSAID’s, chemotherapeutic agents, have 




Acute renal failure refers to the sudden and usually 
reversible loss of renal function which develops over a 
period of days or weeks. There are many causes for 
renal failure which mainly includes acute tubular 
necrosis and commonly occurs for 85% of incidence, 
most acute tubular necrosis occurs either due to 
ischemia or toxins. The toxins may be exogenous 
agents or endogenous agents.
[3]
 
Considering the above incidence of the disease and 
use of the drug in traditional practice the present 
study “To evaluate the Nephro-protective activity of 
Mundi (Sphaeranthus indicus Linn. in Gentamicin 
induced Nephrotoxicity in experimental animals.” is 
selected. 
OBJECTIVE OF THE STUDY   
To do toxicological and experimental evaluation of 
nephroprotective activity of Sphaeranthus indicus 
Linn. 
METHODOLOGY 
Toxicity Study (For dose fixing)
[4] 
Acute Toxicity Study 
Acute oral toxicity study of aqueous and alcoholic 
extract of whole plant of Sphaeranthus indicus Linn. 
was carried out according to OECD guidelines 425 for 
limit test.  
Principle: The limit test is primarily used in situation 
where the experimental has prior information 
indicating that the material to be tested is likely to be 
non-toxic, that is having toxicity only above regulatory 
limit doses. Thus, it allows the starting dose of 2000 
mg/kg and also 5000 mg/kg. the limit test is a 
sequential test that uses a maximum of 4 animals.  
 
 Method: 
 Nulliparous, non-pregnant and 8 to 12 weeks old 
female rats weighing around 200 ± 10gms where 
used 
 A single dose of   Sphaeranthus indicus Linn. 
extract (2000mg/kg b.w) was administrated to 
one of the animals included in the study. 
 A single dose of Sphaeranthus indicus Linn. extract 
(5000mg/kg b.w) was administrated to one of the 
animals included in the study. 
 Based on whether animals survived or died, 
suitable test were performed (if died, main test 
was performed and if survived, same test was 
continued with remaining animals).  
 If three animals died the limit test was terminated 
and the main test was performed. 
 The animals were observed continuously for 2 
hours under following profile.  
Behavioral profile: Spontaneous, restlessness, 
irritability and fearfulness. 
Neurological profile: Spontaneous activity, reactivity, 
touch response, pain response and gait. 
Autonomic profile: Defecation and urination. After 
period of 24 and 72 hours they were observed for any 





 part of the limit test dose 





Acute oral toxicity studies revealed that there is no 
toxicity and no mortality of the rates with aqueous 
and ethanol extract of Sphaeranthus indicus Linn. are 
up to 2000mg /kg and 5000mg / kg body weight even 
after 14 days. 
Preparation of the dose 
Based on the body weight of the animals, dose is 
calculated separately for each animals and dose is 
fixed. For 1gm of drug , 5ml of distilled water is added 
and finely triturated with 0.1 gm of 2% of gum acacia 
and given orally with the help of gastric canula dose is 
given individually based on the body weight of the 
animals which were marked prior.  
 Based on the short term toxicity profile, the 
consecutive dose of the extract was determined 
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as per OECD guideline 425 the maximum dose 
tested (2000mg/kg) for LD50. 2000 mg/kg body 
weight is the dose fixed as per Limit test. 
 From the LD50 doses like  1/5th of 2000mg = 
400mg/kg body weight is the high dose 1/10
th
 of 
2000mg = 200mg/kg body weight is the low dose 
is taken to carry out this study.    
Experimental Study 
Place of Work 
The toxicological and experimental study was carried 
out in Department of Pharmacology, Acharya & B.M. 
Reddy College of Pharmacy, Bengaluru. 
Ethical Clearance 
The experimental procedure was carried out in 
accordance with the ethical guidelines for animals 
proposed by CPCSEA, Government of India. Ethical 
clearance was obtained from Department of 
Pharmacology, Acharya & B.M Reddy College of 
Pharmacy, Bengaluru as per the protocol outlined in 
publication of the committee for the purpose of 
control and supervision of experiments on animals’ 
standard guidelines (CPCSEA) and approval was 
obtained from Institutional Animal Ethics committee 
(IAEC) with reference no: IAEC/ABMRCP/2018-2019/8. 
Dated 30/09/2018 
Selection of Animals Maintenance 
The required number of healthy Wistar Albino rats of 
both the sex weighing 150250g were procured from 
animal house, Acharya & B.M Reddy college of 
Pharmacy, Bengaluru. Animals were maintained under 
controlled temperature at 270 ± 20C and 12hours 
light and dark cycles.   
Animals were housed in polypropylene cage and free 
access to standard pellets and water ablibidum 
Examination of the Animals prior to the experiment 
 All the Wistar albino rats were subjected to 
general check-up for sex and weight. 
 Weight of each animal was checked by using 
balance.  
 Identification of the animals was done by specific 
marking with picric acid. 
 The cages were labelled with the number of 
animals and dosage groups.  
Inclusion Criteria 
Albino-wistar strain rats weighing 150-250 g. of either 
sex are selected, healthy with normal behaviour and 
activity.  
Exclusion Criteria  
 Albino -wistar strain rats which are pregnant. 
 Albino-wistar strain rats showing signs of infection 
during the course of study.   
 Albino-wistar rats under other experiments.  
Route of administration: The drugs were 




Table 1: For experimental evaluation of 
nephroprotective activity 











6 Inj Gentamicin 80mg/kg 
body wt IP 
3. Aq. Extract 
low dose 
(200mg)  
6 Inj Gentamicin 80mg/kg 
body wt IP 
+ Aq  Extract low dose  
 
4. Aq. Extract 
high dose  
(400mg) 
6 Inj Gentamicin 80mg/kg 







6 Inj Gentamicin 80mg/kg 
body wt IP + Ethanolic 
extract (Low dose)  
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6 Inj Gentamicin 80mg/kg 
body wt IP + Ethanolic 
extract high dose  
 
Group - 1 served as health control; received purified 
water (5ml/kg, p.o.).   
Group - 2 served as Nephrotoxic control; This group of 
animals received daily i.p. injection of gentamicin 
(80mg/kg body weight) for eight days.   
Group 3,4,5,6 animals of this group received 80 mg/kg 
of gentamicin i.p. nearly for eight days in addition to 
this they also received aqueous extract low dose 
(200mg), aqueous extract high dose (400mg), 
ethanolic extract low dose (200mg) and ethanolic 
extract high dose (400mg) respectively which was 
started three days prior to the gentamicin injection 
and continued with 8 days  gentamicin treatment.    
Analysis of General Parameters   
a) Estimation of Body weight: All the animals of 
each group are weighed individually at the 
beginning and end of the study,  
b) Estimation of urine glucose.  
 Each group of one animal was kept in individual 




 All the animals were free access to drinking water 
during the urine collection period.  
 Urine was analyzed for glucose  
c) Blood collection techniques used in the present 
study:
 
At the end of the experimental period, i.e. 
on the 11
th
 day, the blood was collected by retro-
orbital vein puncture using a fine capillary to an 
anticoagulant tube and allowed to stand for 30 
min at 37°C and then centrifuged to separate the 
serum to evaluate the biochemical markers.
[7] 
  
d) Analysis of serum biochemical parameters 
 Estimation of Serum creatinine.  
 Estimation of Serum urea.  
  Estimation of Serum protein.  
e) Histopathology analysis 
At the end of the experimental period, i.e. on the 11
th
 
day, the abdomen was cut opened to remove both 
kidneys from one animal of each group. Isolated 
kidneys were cleaned off extraneous tissue and 
preserved in 10% Neutral Formalin. 
f) Preparation of kidney homogenate[7] 
The kidney was quickly removed and perfused 
immediately with ice-cold saline (0.9% NaCl). A 
portion of the kidney was homogenized in chilled Tris-
HCl buffer (0.025 M, pH 7.4) using a homogenizer. The 
homogenate obtained was centrifuged at 5000 rpm 
for 10 minutes, supernatant was collected and used 
for various biochemical assays.   
Statistical Analysis 
The results were expressed in mean ± S.E.M. The 
difference among the data was statically analysed 
using one–way ANOVA followed by Turkey’s test to 
determine the level of significance using prism, graph 
pad version5, (Graph pad software Inc.) difference 
between the data were considered significant at P < 
0.05. 
RESULTS 
Assessment of General Parameters 
Table 2: Representation of effect of AESI & EESI on 
Urea, Creatinine, Total protein, Urine Glucose, and 
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Values are expressed in mean ± S.E.M.(n=6), **=p<0.01 and 
***=p<0.001 
Table 3: Representation of effect AESI & EESI on 
Blood Urea in 6 groups of Experimental Study.               
Group  Urea (mg/dL) 
Group 1 20.5±0.9 
Group 2 56±1.4 
Group 3 38.5±0.6 *** 
Group 4 26±1.2 *** 
Group 5 35.75±1.3 *** 
Group 6 28.75±0.8 *** 
Fig. 1: Diagrammatic representation of effect AESI & 
EESI on Blood Urea in 6 groups of Experimental 
Study.               
 
Results  
Effect of extract on Serum Urea 
Animals in group 1 served as control group showed 
normal levels of serum urea (20.5±0.9 mg/dL). The 
effect of different doses of aqueous and ethanolic 
extracts on serum urea is demonstrated in Figure 1. In 
groups 3, 4, 5 and 6 rats treated with lower and higher 
doses of aqueous and ethanolic extracts respectively 
showed significantly (P < 0.05) decrease in serum urea 
levels i.e. 38.5±0.6, 26±1.2, 35.37±1.3 and 28.75±0.8 
mg/dL respectively compared to negative control 
group i.e. 56±1.4 mg/dL.  
Table 4: Representation of effect AESI and EESI on 
Serum Creatinin in 6 groups of Experimental Study. 
Group  Creatinine (mg/dL) 
Group 1 0.75±0.06 
Group 2 2.25±0.06 
Group 3 1.77±0.06 *** 
Group 4 1.1±0.07 *** 
Group 5 1.8±0.04 ** 
Group 6 1.12±0.08 *** 
Fig. 2: Diagrammatic representation of effect AESI 
and EESI on Serum Creatinin in 6 groups of 
Experimental Study.   
 
Results  
Effect of extract on Serum Creatinine 
Group 1 animals served as control group showed 
normal levels of serum creatinine (0.75±0.06 mg/dL). 
The effect of different doses of aqueous and ethanolic 
extracts on serum creatinine is demonstrated 
in Figure 2. In groups 3, 4, 5 and 6 rats treated with 
lower and higher doses of aqueous and ethanolic 
extracts respectively showed significantly (P < 0.05) 
decrease in serum creatinine levels i.e. 1.77±0.06, 
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1.1±0.07, 1.8±0.04 and 1.12±0.08 mg/dL respectively 
compared to negative control group i.e. 2.25±0.06 
mg/dL. 
Table 5: Representation of effect AESI and EESI on 
Conc. of Total Proteins in 6 groups of Experimental 
Study.        
Group  Total Protein (g/dL) 
Group 1 6.47±0.11 
Group 2 12.9±0.24 
Group 3 8.45±0.15 *** 
Group 4 6.75±0.06 *** 
Group 5 8.55±0.1 *** 
Group 6 6.6±0.16 *** 
Fig. 3: Diagrammatic representation of effect AESI 




Effect of extract on Total protein 
Group 1 rats served as control group showed normal 
levels of total protein (6.47±0.11 g/dL). The effect of 
different doses of aqueous and ethanolic extracts on 
total protein is demonstrated in Figure 3. In groups 3, 
4, 5 and 6 rats treated with lower and higher doses of 
aqueous and ethanolic extracts respectively showed 
significantly (P < 0.05) decrease in total protein levels 
i.e. 8.45±0.15, 6.75±0.06, 8.55±0.1 and 6.6±0.16 g/dL 
respectively compared to negative control group i.e. 
12.9±0.24 g/dL. 
Table 6: Representationof effect AESI and EESI on 
Conc.of Urine Glucose in 6 groups of Experimental 
Study. 
Group  Urine Glucose (mg/dL) 
Group 1 13.25±0.85 
Group 2 27±0.91 
Group 3 18.75±0.85 *** 
Group 4 14.5±0.64 *** 
Group 5 19.5±1.19 *** 
Group 6 14.75±0.85 *** 
Fig. 4: Diagrammatic representationof effect AESI 




Effect of extract on Urine glucose levels 
Animals in group 1 served as control group showed 
normal levels of urine glucose (13.25±0.85 mg/dL). 
The effect of different doses of aqueous and ethanolic 
extracts on urine glucose is demonstrated in Figure 4. 
In groups 3, 4, 5 and 6 rats treated with lower and 
higher doses of aqueous and ethanolic extracts 
respectively showed significantly (P < 0.05) decrease 
in urine glucose levels i.e. 18.75±0.85, 14.5±0.64, 
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19.5±1.19 and 14.75±0.85 mg/dL respectively 
compared to negative control group i.e. 27±0.91 
mg/dL.  
Table 7: Diagrammatic representationof effect AESI 
and EESI on Kidney Weight in 6 groups of 
Experimental Study. 
Fig. 5: Diagrammatic representationof effect AESI 




Effect of extract on Kidney weight 
Group 1 animals served as control group showed 
normal of kidney weight (0.54±0.01 g). The effect of 
different doses of aqueous and ethanolic extracts on 
kidney weight is demonstrated in Figure 5. In groups 
3, 4, 5 and 6 rats treated with lower and higher doses 
of aqueous and ethanolic extracts respectively 
showed significantly (P < 0.05) decrease in kidney 
weight i.e. 0.72±0.01, 0.61±0.01, 0.73±0.02 and 
0.62±0.01 g respectively compared to negative control 
group i.e. 0.85±0.22 g.  
Histopathological Studies  
Group 1: Health Control.Control Kidney showing 
normal architecture of glomerulus containing tuft of 
capillaries surrounded by Bowman’s capsule (arrow).  
The proximal and distal convoluted tubules lined by 
columnar epithelial cells (asterisk).  
Group 2: Nephrotoxic Control. Nephrotoxic Kidney 
showing disruption in the architecture with severe 
degeneration of glomerulus and accumulation of 
edema fluid (arrow), congestion of  blood vessel.  The 
proximal and distal convoluted tubules lined by 
columnar epithelial cells are showing vacuolar 
degeneration with swollen cells (asterisk).  
Group 3: Inj Gentamicin + Aq Extract low dose, low 
dose Kidney showing normal architecture with 
moderate degeneration of glomerulus (arrow), 
congestion of blood vessels. The proximal and distal 
convoluted tubules lined by columnar epithelial cells 
are showing vacuolar degeneration with cell debris in 
the lumen (asterisk).  
Group 4: Inj Gentamicin + Aq  Extract high dose. High 
dose Kidney showing normal architecture of 
glomerulus with tuft of blood capillaries surrounded 
by Bowman’s capsule (arrow) with mild congestion of 
blood vessels. The proximal and distal convoluted 
tubules lined by columnar epithelial cells are showing 
normal architecture (asterisk).  
Group 5: Inj Gentamicin + Ethanolic extract (Low 
dose), low dose Kidney showing normal architecture 
with moderate degeneration of glomerulus with loss 
of blood capillaries (arrow) with mild congestion of 
blood vessels. The proximal and distal convoluted 
tubules lined by columnar epithelial cells are showing 
vacuolar degeneration, swollen cells and edema fluid 
accumulation (asterisk). Haematoxylin and Eosin stain, 
scale bar=100μm. 
Group  Kidney Weight (g) 
Group 1 0.54±0.01 
Group 2 0.85±0.22 
Group 3 0.72±0.01*** 
Group 4 0.61±0.01*** 
Group 5 0.73±0.02*** 
Group 6 0.62±0.01*** 
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Group 6: Inj Gentamicin 80mg/kg body wtIP + 
Ethanolic extract high dose, high dose Kidney showing 
normal architecture with mild degeneration of 
glomerulus with loss of blood capillaries and vacuoles 
(arrow) with mild congestion of blood vessels. The 
proximal and distal convoluted tubules lined by 
columnar epithelial cells are showing vacuolar 
degeneration and cell debris in the lumen (asterisk).  
Plate 1:  Histopathology pictures of kidneys of rats 
 
DISCUSSION 
Discussion on experimental study  
Aqueous extract and ethenolic extract of 
Sphaeranthus indicus Linn. is used for the study to 
compare with gentamicin induced nephrotoxicity in 
rats. The animal models employed for screening of 
nephrotoxicity and nephron protective effect of the 
drug. 
The acute toxicity studies done suggested that drug is 
nontoxic up to 2000-4000mg/kg, this revealed that 
drug is safe and appreciated for use in very high dose 
also.  
The data related to serum biochemical parameter 
indicates that injection of gentamicin causes highly 
significant elevation indicating that the protocol 
employed produces significant kidney injury, 
remarkable reversal of these changes by both the test 
extracts indicates presence of significant 
nephroprotective activity. The observed effect was 
dose depended further there was no significant 
difference between aqueous and ethanol extracts. 
The above results were further correlated by the 
histopathological examination in which gentamicin 
was focused to be produced. The toxicants induced 
changes were found to be significantly less in test 
extract administered groups in comparison to 
gentamicin control.   
Discussion on histopathological study 
Plate 1- Examination of kidney sections from normal 
control group showed normal sito architecture in both 
cortex and medullary regions. Plate 1 repeats 
representative photo micrograph from this group. 
Plate 2- Microscopic examination of kidney sections 
from gentamicin control group showed marked 
degenerative changes. This was evident in the form of 
nephrotic oedema, marked necrotic changes in 
tubular epithelium, accumulation of proteous material 
in the tubules also occur. Plate 2 repeats 
photomicrograph of representative section from this 
group.   
Plate 3- Examination of kidney sections from 
gentamicin injected, low dose aqueous extract 
administered group revealed comparatively moderate 
degenerative changes in comparison to gentamicin 
induced group, only moderate degenerative changes 
in the tubular epithelium, proteous material, 
accumulation in tubular lumen is low.  
Plate 4- Examination of sections of kidney from 
gentamicin injected, high dose aqueous extract 
administered group revealed almost normal sito 
architecture, glomeruli and tubules, blood vessels are 
found to be normal no significant degenerative 
changes to be observed. 
Plate 5- Examination of sections of kidney from 
gentamicin injected, low dose ethanolic extract 
administered group revealed, moderate to severe 
degenerative changes in the form of glomular 
congestion, increase in peri glomerular, extensive 
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diffused tubular necrosis, accumulation of protiaus 
material and mild cell degeneration  
Plate 6- Examination of sections of kidney from 
gentamicin injected, High dose ethanolic extract 
administered group revealed, mild degenerative 
changes in the form of glomerular dilatation and 
diffused degenerative changes in the tubular 
epithelium, and otherwise the section exhibited 
normal sito architecture.   
CONCLUSION  
Toxicological studies showed that the drug is safe for 
use in both lower and higher doses. Hence Mundi can 
be used as drug of choice in renal diseases. 
Histopathological parameters justified that both 
aqueous and ethanol extracts showed 
nephroprotective activity, when compared between 
these, aqueous extract  with high dose was proven to 
be better than other extracts.  
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